Penumbra Inc. (PEN)
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
PEN's Q3 results impress with double-digit sales growth, margin expansion and a strong 20% stock surge after its earnings beat.
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Penumbra, Inc. (PEN) Q3 2025 Earnings Call Transcript
Penumbra, Inc. ( PEN ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Cecilia Furlong Adam Elsesser - Co-Founder, Chairman & CEO Shruthi Narayan - President Maggie Yuen - Chief Financial Officer Conference Call Participants Travis Steed - BofA Securities, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Joanne Wuensch - Citigroup Inc., Research Division Vijay Kumar - Evercore Inc. Brandon Vazquez - William Blair & Company L.L.C., Research Division William Plovanic - Canaccord Genuity Corp., Research Division Michael Sarcone - Jefferies LLC, Research Division Pito Chickering - Deutsche Bank AG, Research Division Ryan Zimmerman - BTIG, LLC, Research Division Presentation Operator Ladies and gentlemen, good afternoon.
Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Penumbra (PEN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Penumbra (PEN) Q3 Earnings and Revenues Beat Estimates
Penumbra (PEN) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.85 per share a year ago.
Penumbra, Inc. (PEN) Presents at Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 Transcript
Penumbra, Inc. (NYSE:PEN ) Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 October 26, 2025 7:00 PM EDT Company Participants Adam Elsesser - Co-Founder, Chairman & CEO Shruthi Narayan - President James Benenati - Chief Medical Officer Conference Call Participants Robert Lookstein William Plovanic - Canaccord Genuity Corp., Research Division Rachel Rosovsky Stavros Konstantinides Robert Marcus - JPMorgan Chase & Co, Research Division Christopher Pasquale - Nephron Research LLC Joanne Wuensch - Citigroup Inc., Research Division Pito Chickering - Deutsche Bank AG, Research Division Richard Newitter - Truist Securities, Inc., Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Michael Kratky - Leerink Partners LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division David Rescott - Robert W.
Penumbra, Inc. (PEN) Q2 2025 Earnings Call Transcript
Penumbra, Inc. (NYSE:PEN ) Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ET Company Participants Adam Elsesser - Co-Founder, Chairman, President & CEO Cecilia Furlong - Corporate Participant Jason Richard Mills - Executive Vice President of Strategy Maggie S. Yuen - Chief Financial Officer Conference Call Participants Brandon Vazquez - William Blair & Company L.L.C.
Penumbra (PEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Penumbra (PEN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates
Penumbra (PEN) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.64 per share a year ago.
Will Penumbra (PEN) Beat Estimates Again in Its Next Earnings Report?
Penumbra (PEN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Penumbra (PEN) Reports Next Week: Wall Street Expects Earnings Growth
Penumbra (PEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
